Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 23-May-13 4:50 PM View:  | Ritter Allen R VP of Manufacturing/CMC | Endocyte, Inc. (ECYT) | 23-May-13 | Option Exercise | 5,000 | $2.10 | $10,500.00 | 39% 12.72K to 17.72K | |
| 22-May-13 6:30 PM View: | Hanham Ann Director | Endocyte, Inc. (ECYT) | 22-May-13 | Market Sale | 16,400 | $14.39 | $235,996.00 | (2%) 731.74K to 715.34K | 1% |
| 23-May-13 4:47 PM View: | Nguyen Binh VP of Clinical Affairs | Endocyte, Inc. (ECYT) | 22-May-13 | Option Exercise | 2,700 | $3.55 | $9,585.00 | 100% 0 to 2.7K | |
| 22-May-13 6:30 PM View: | Hanham Ann Director | Endocyte, Inc. (ECYT) | 21-May-13 | Market Sale | 11,000 | $14.31 | $157,410.00 | (1%) 742.74K to 731.74K | < 1% |
| 22-May-13 4:02 PM View: | Ritter Allen R VP of Manufacturing/CMC | Endocyte, Inc. (ECYT) | 21-May-13 | Market Sale (Planned) | 483 | $14.17 | $6,844.11 | (4%) 13.21K to 12.72K | (< 1%) |
| 22-May-13 6:30 PM View: | Hanham Ann Director | Endocyte, Inc. (ECYT) | 20-May-13 | Market Sale | 12,600 | $14.42 | $181,692.00 | (2%) 755.34K to 742.74K | 1% |
| 20-May-13 4:38 PM View: | Hanham Ann Director | Endocyte, Inc. (ECYT) | 17-May-13 | Market Sale | 14,600 | $14.37 | $209,802.00 | (2%) 769.93K to 755.34K | (< 1%) |
| 21-May-13 5:46 PM View: | Nguyen Binh VP of Clinical Affairs | Endocyte, Inc. (ECYT) | 17-May-13 | Option Exercise | 17,300 | $3.55 | $61,415.00 | 100% 0 to 17.3K | |
| 21-May-13 5:46 PM View: | Nguyen Binh VP of Clinical Affairs | Endocyte, Inc. (ECYT) | 17-May-13 | Market Option Sale | 17,300 | $14.42 | $249,466.00 | (100%) 17.3K to 0 | 2% |
| 20-May-13 4:38 PM View: | Hanham Ann Director | Endocyte, Inc. (ECYT) | 16-May-13 | Market Sale | 22,600 | $14.44 | $326,344.00 | (3%) 792.53K to 769.93K | < 1% |
| 16-May-13 5:16 PM View: | Hanham Ann Director | Endocyte, Inc. (ECYT) | 15-May-13 | Market Sale | 20,000 | $14.43 | $288,600.00 | (2%) 812.53K to 792.53K | (< 1%) |
| 16-May-13 4:34 PM View: | Leamon Christopher P Vice President of Research | Endocyte, Inc. (ECYT) | 14-May-13 | Market Sale | 5,000 | $14.70 | $73,500.00 | (33%) 15.07K to 10.07K | 1% |
| 16-May-13 5:16 PM View: | Hanham Ann Director | Endocyte, Inc. (ECYT) | 14-May-13 | Market Sale | 20,200 | $14.94 | $301,788.00 | (2%) 832.74K to 812.53K | 3% |
| 08-May-13 4:32 PM View: | Ritter Allen R VP of Manufacturing/CMC | Endocyte, Inc. (ECYT) | 07-May-13 | Market Sale (Planned) | 500 | $13.51 | $6,755.00 | (4%) 13.71K to 13.21K | < 1% |
| 03-May-13 4:34 PM View: | Ellis P Ron President and CEO Director | Endocyte, Inc. (ECYT) | 01-May-13 | Market Sale (Planned) | 500 | $13.88 | $6,940.00 | (< 1%) 104.99K to 104.49K | 1% |
| 18-Apr-13 6:00 PM View: | Ritter Allen R VP of Manufacturing/CMC | Endocyte, Inc. (ECYT) | 16-Apr-13 | Market Sale (Planned) | 500 | $13.22 | $6,610.00 | (4%) 14.21K to 13.71K | (2%) |
| 03-Apr-13 9:00 PM View: | Ritter Allen R VP of Manufacturing/CMC | Endocyte, Inc. (ECYT) | 02-Apr-13 | Market Sale (Planned) | 500 | $12.48 | $6,240.00 | (3%) 14.71K to 14.21K | (6%) |
| 03-Apr-13 9:01 PM View: | Ellis P Ron President and CEO Director | Endocyte, Inc. (ECYT) | 01-Apr-13 | Market Sale (Planned) | 500 | $12.54 | $6,270.00 | (< 1%) 105.49K to 104.99K | (5%) |
| 29-Mar-13 7:01 PM View: | Ellis P Ron President and CEO Director | Endocyte, Inc. (ECYT) | 27-Mar-13 | Market Sale (Planned) | 1,500 | $12.00 | $18,000.00 | (1%) 106.99K to 105.49K | (4%) |
| 27-Mar-13 4:46 PM View: | Ritter Allen R VP of Manufacturing/CMC | Endocyte, Inc. (ECYT) | 25-Mar-13 | Market Sale (Planned) | 1,000 | $11.00 | $11,000.00 | (6%) 15.71K to 14.71K | 2% |
| 18-Mar-13 9:30 PM View: | Ritter Allen R VP of Manufacturing/CMC | Endocyte, Inc. (ECYT) | 13-Mar-13 | Option Exercise | 12,722 | $1.91 | $24,299.00 | 426% 2.98K to 15.71K | |
| 26-Feb-13 5:16 PM View: | Lovejoy Chandra D VP of Regulatory Affairs | Endocyte, Inc. (ECYT) | 25-Feb-13 | Option Exercise | 2,102 | $3.02 | $6,355.51 | 100% 0 to 2.1K | |
| 26-Feb-13 5:16 PM View: | Lovejoy Chandra D VP of Regulatory Affairs | Endocyte, Inc. (ECYT) | 25-Feb-13 | Market Option Sale (Planned) | 2,102 | $9.70 | $20,389.40 | (100%) 2.1K to 0 | 6% |
| 20-Feb-13 4:16 PM View: | Ritter Allen R VP of Manufacturing/CMC | Endocyte, Inc. (ECYT) | 19-Feb-13 | Market Sale (Planned) | 500 | $10.03 | $5,015.00 | (14%) 3.48K to 2.98K | 2% |
| 20-Feb-13 4:16 PM View: | Ritter Allen R VP of Manufacturing/CMC | Endocyte, Inc. (ECYT) | 15-Feb-13 | Market Sale (Planned) | 500 | $10.00 | $5,000.00 | (13%) 3.98K to 3.48K | 1% |
| 04-Feb-13 4:11 PM View: | Ritter Allen R VP of Manufacturing/CMC | Endocyte, Inc. (ECYT) | 31-Jan-13 | Market Sale (Planned) | 1,000 | $10.00 | $10,000.00 | (20%) 4.98K to 3.98K | < 1% |
| 29-Jan-13 6:15 PM View: | Lovejoy Chandra D VP of Regulatory Affairs | Endocyte, Inc. (ECYT) | 25-Jan-13 | Option Exercise | 2,209 | $2.92 | $6,456.95 | 100% 0 to 2.21K | |
| 29-Jan-13 6:15 PM View: | Lovejoy Chandra D VP of Regulatory Affairs | Endocyte, Inc. (ECYT) | 25-Jan-13 | Market Option Sale (Planned) | 2,209 | $9.56 | $21,118.00 | (100%) 2.21K to 0 | 2% |
| 03-Jan-13 1:00 PM View: | Ellis P Ron President and CEO Director | Endocyte, Inc. (ECYT) | 31-Dec-12 | Market Sale (Planned) | 6,000 | $8.75 | $52,500.00 | (5%) 113.79K to 107.79K | (9%) |
| 28-Dec-12 4:07 PM View: | Lovejoy Chandra D VP of Regulatory Affairs | Endocyte, Inc. (ECYT) | 26-Dec-12 | Market Option Sale (Planned) | 2,209 | $9.05 | $19,991.50 | (100%) 2.21K to 0 | (10%) |
| 28-Dec-12 4:07 PM View: | Lovejoy Chandra D VP of Regulatory Affairs | Endocyte, Inc. (ECYT) | 26-Dec-12 | Option Exercise | 2,209 | $2.54 | $5,610.86 | 100% 0 to 2.21K | |
| 20-Dec-12 2:55 PM View: | Ritter Allen R VP of Manufacturing/CMC | Endocyte, Inc. (ECYT) | 18-Dec-12 | Market Sale (Planned) | 2,000 | $9.65 | $19,300.00 | (29%) 6.98K to 4.98K | (4%) |
| 13-Dec-12 2:30 PM View: | Sanderling Ventures Managem... 10% Owner | Endocyte, Inc. (ECYT) | 11-Dec-12 | Disposition (other) | 182,947 | -- | -- | (100%) 182.95K to 0 | |
| 27-Nov-12 4:26 PM View: | Ritter Allen R VP of Manufacturing/CMC | Endocyte, Inc. (ECYT) | 26-Nov-12 | Market Sale (Planned) | 2,000 | $9.00 | $18,000.00 | (22%) 8.98K to 6.98K | (11%) |
| 27-Nov-12 4:18 PM View: | Lovejoy Chandra D VP of Regulatory Affairs | Endocyte, Inc. (ECYT) | 26-Nov-12 | Option Exercise | 2,209 | $2.54 | $5,610.86 | 100% 0 to 2.21K | |
| 27-Nov-12 4:18 PM View: | Lovejoy Chandra D VP of Regulatory Affairs | Endocyte, Inc. (ECYT) | 26-Nov-12 | Market Option Sale (Planned) | 2,209 | $8.72 | $19,262.50 | (100%) 2.21K to 0 | (15%) |
| 05-Nov-12 5:46 PM View: | Ritter Allen R VP of Manufacturing/CMC | Endocyte, Inc. (ECYT) | 01-Nov-12 | Market Sale (Planned) | 5,000 | $9.40 | $47,000.00 | (36%) 13.98K to 8.98K | (6%) |
| 29-Oct-12 7:04 AM View: | Lovejoy Chandra D VP of Regulatory Affairs | Endocyte, Inc. (ECYT) | 25-Oct-12 | Option Exercise | 2,209 | $2.54 | $5,610.86 | 100% 0 to 2.21K | |
| 29-Oct-12 7:04 AM View: | Lovejoy Chandra D VP of Regulatory Affairs | Endocyte, Inc. (ECYT) | 25-Oct-12 | Market Option Sale (Planned) | 2,209 | $9.71 | $21,449.40 | (100%) 2.21K to 0 | (3%) |
| 01-Oct-12 4:12 PM View: | Low Philip S Chief Science Officer Director | Endocyte, Inc. (ECYT) | 28-Sep-12 | Market Sale | 34,000 | $9.99 | $339,810.00 | (8%) 419.12K to 385.12K | < 1% |
| 27-Sep-12 4:29 PM View: | Lovejoy Chandra D VP of Regulatory Affairs | Endocyte, Inc. (ECYT) | 25-Sep-12 | Market Option Sale (Planned) | 2,209 | $10.28 | $22,708.70 | (100%) 2.21K to 0 | 3% |
| 27-Sep-12 4:29 PM View: | Lovejoy Chandra D VP of Regulatory Affairs | Endocyte, Inc. (ECYT) | 25-Sep-12 | Option Exercise | 2,209 | $2.54 | $5,610.86 | 100% 0 to 2.21K | |
| 17-Aug-12 4:41 PM View: | Leamon Christopher P Vice President of Research | Endocyte, Inc. (ECYT) | 16-Aug-12 | Market Sale | 10,000 | $9.65 | $96,535.00 | (40%) 25.07K to 15.07K | (4%) |
| 07-Jun-12 4:18 PM View: | Hanham Ann Director | Endocyte, Inc. (ECYT) | 06-Jun-12 | Market Sale | 314,900 | $6.60 | $2,079,380.00 | (27%) 1.15M to 832.74K | (51%) |
| 07-Jun-12 4:18 PM View: | Hanham Ann Director | Endocyte, Inc. (ECYT) | 05-Jun-12 | Market Sale | 10,200 | $6.60 | $67,349.60 | (< 1%) 1.16M to 1.15M | (51%) |
| 18-May-12 4:09 PM View: | Hanham Ann Director | Endocyte, Inc. (ECYT) | 16-May-12 | Market Sale | 27,900 | $6.65 | $185,552.00 | (2%) 1.23M to 1.2M | (19%) |
| 16-May-12 5:48 PM View: | Hanham Ann Director | Endocyte, Inc. (ECYT) | 15-May-12 | Market Sale | 40,000 | $6.68 | $267,148.00 | (3%) 1.23M to 1.19M | (49%) |
| 16-May-12 5:48 PM View: | Hanham Ann Director | Endocyte, Inc. (ECYT) | 14-May-12 | Market Sale | 107,000 | $6.94 | $742,088.00 | (8%) 1.33M to 1.23M | (44%) |
| 01-Oct-12 4:12 PM View: | Low Philip S Chief Science Officer Director | Endocyte, Inc. (ECYT) | 20-Jan-12 | Gift | 15,000 | -- | -- | (3%) 434.12K to 419.12K | |
| 22-Dec-11 8:28 PM View: | Sanderling Venture Partners... 10% Owner | Endocyte, Inc. (ECYT) | 21-Dec-11 | Market Purchase | 217,800 | $3.16 | $688,248.00 | 6% 3.37M to 3.59M | 216% |
